PATENT CLAIM ANALYSIS

Application Number: 15771704
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["424", "472000"]

Abstract:
This invention relates to pharmaceutical controlled release compositions of salicylate-releasing actives for the treatment of tau protein-related neurodegenerative diseases and disorders.

Claim (Index 16):
The oral pharmaceutical composition of  claim 14 , wherein the amount of salsalate in the immediate release component is about 20 to about 40 wt. %, the amount of salsalate in the delayed release component coated with pharmaceutically acceptable enteric polymer that substantially dissolves at about pH 6 is about 10 to about 30 wt. %, and the amount of salsalate in the delayed release component coated with pharmaceutically acceptable enteric polymer that substantially dissolves at about pH 7 is about 40 to about 60 wt. %.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15543199', '15010212', '10015930', '13186006', '11120139']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7568057867881632
- 35 USC 102 Novelty (BERT): 0.5017768339437033
- Combined Prediction Score: 0.7313028915037173
- Mean Citation Score: 237.953648
- Max Citation Score: 264.3504
- Similarity Product: 200.06928406505585

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test